Annual EBITDA
-$32.04 M
+$30.75 M+48.97%
December 31, 2023
Summary
- As of February 8, 2025, DTIL annual EBITDA is -$32.04 million, with the most recent change of +$30.75 million (+48.97%) on December 31, 2023.
- During the last 3 years, DTIL annual EBITDA has risen by +$67.15 million (+67.70%).
- DTIL annual EBITDA is now -58.05% below its all-time high of -$20.27 million, reached on December 31, 2021.
Performance
DTIL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$15.16 M
-$49.85 M-143.69%
September 30, 2024
Summary
- As of February 8, 2025, DTIL quarterly EBITDA is -$15.16 million, with the most recent change of -$49.85 million (-143.69%) on September 30, 2024.
- Over the past year, DTIL quarterly EBITDA has dropped by -$25.75 million (-243.15%).
- DTIL quarterly EBITDA is now -143.69% below its all-time high of $34.69 million, reached on June 30, 2024.
Performance
DTIL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$18.82 M
-$5.66 M-23.12%
September 30, 2024
Summary
- As of February 8, 2025, DTIL TTM EBITDA is $18.82 million, with the most recent change of -$5.66 million (-23.12%) on September 30, 2024.
- Over the past year, DTIL TTM EBITDA has increased by +$29.13 million (+282.69%).
- DTIL TTM EBITDA is now -23.12% below its all-time high of $24.48 million, reached on June 30, 2024.
Performance
DTIL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DTIL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.0% | -243.2% | +282.7% |
| 3 y3 years | +67.7% | -36.0% | +127.1% |
| 5 y5 years | +26.6% | -36.0% | +127.1% |
DTIL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.0% | +49.0% | -143.7% | +47.1% | -23.1% | +121.6% |
| 5 y | 5-year | -58.0% | +67.7% | -143.7% | +49.9% | -23.1% | +118.8% |
| alltime | all time | -58.0% | +67.7% | -143.7% | +50.6% | -23.1% | +118.8% |
Precision BioSciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.16 M(-143.7%) | $18.82 M(-23.1%) |
| Jun 2024 | - | $34.69 M(+227.6%) | $24.48 M(-337.6%) |
| Mar 2024 | - | $10.59 M(-193.7%) | -$10.30 M(-67.8%) |
| Dec 2023 | -$32.04 M(-49.0%) | -$11.30 M(+19.0%) | -$32.04 M(-14.3%) |
| Sep 2023 | - | -$9.50 M(+9897.9%) | -$37.41 M(-8.6%) |
| Jun 2023 | - | -$95.00 K(-99.1%) | -$40.95 M(-41.1%) |
| Mar 2023 | - | -$11.15 M(-33.1%) | -$69.49 M(-17.5%) |
| Dec 2022 | -$62.79 M(+209.7%) | -$16.67 M(+27.8%) | -$84.21 M(-3.5%) |
| Sep 2022 | - | -$13.04 M(-54.5%) | -$87.28 M(+5.3%) |
| Jun 2022 | - | -$28.63 M(+10.7%) | -$82.89 M(+177.1%) |
| Mar 2022 | - | -$25.87 M(+31.0%) | -$29.92 M(+47.6%) |
| Dec 2021 | -$20.27 M | -$19.74 M(+128.2%) | -$20.27 M(-5.8%) |
| Sep 2021 | - | -$8.65 M(-135.5%) | -$21.51 M(-40.9%) |
| Jun 2021 | - | $24.34 M(-250.1%) | -$36.38 M(-60.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.22 M(-22.7%) | -$90.97 M(-8.9%) |
| Dec 2020 | -$99.19 M(+13.5%) | -$20.98 M(-10.8%) | -$99.85 M(+1.9%) |
| Sep 2020 | - | -$23.52 M(-22.3%) | -$97.98 M(+4.5%) |
| Jun 2020 | - | -$30.25 M(+20.5%) | -$93.80 M(+14.6%) |
| Mar 2020 | - | -$25.11 M(+31.4%) | -$81.82 M(-6.4%) |
| Dec 2019 | -$87.38 M(+100.0%) | -$19.11 M(-1.2%) | -$87.38 M(+5.4%) |
| Sep 2019 | - | -$19.34 M(+5.9%) | -$82.92 M(+14.0%) |
| Jun 2019 | - | -$18.27 M(-40.4%) | -$72.75 M(+10.6%) |
| Mar 2019 | - | -$30.66 M(+109.4%) | -$65.79 M(+50.6%) |
| Dec 2018 | -$43.68 M(+113.9%) | -$14.64 M(+59.7%) | -$43.68 M(+50.4%) |
| Sep 2018 | - | -$9.17 M(-18.9%) | -$29.04 M(+46.2%) |
| Jun 2018 | - | -$11.31 M(+32.3%) | -$19.87 M(+132.3%) |
| Mar 2018 | - | -$8.55 M | -$8.55 M |
| Dec 2017 | -$20.42 M | - | - |
FAQ
- What is Precision BioSciences annual EBITDA?
- What is the all time high annual EBITDA for Precision BioSciences?
- What is Precision BioSciences annual EBITDA year-on-year change?
- What is Precision BioSciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Precision BioSciences?
- What is Precision BioSciences quarterly EBITDA year-on-year change?
- What is Precision BioSciences TTM EBITDA?
- What is the all time high TTM EBITDA for Precision BioSciences?
- What is Precision BioSciences TTM EBITDA year-on-year change?
What is Precision BioSciences annual EBITDA?
The current annual EBITDA of DTIL is -$32.04 M
What is the all time high annual EBITDA for Precision BioSciences?
Precision BioSciences all-time high annual EBITDA is -$20.27 M
What is Precision BioSciences annual EBITDA year-on-year change?
Over the past year, DTIL annual EBITDA has changed by +$30.75 M (+48.97%)
What is Precision BioSciences quarterly EBITDA?
The current quarterly EBITDA of DTIL is -$15.16 M
What is the all time high quarterly EBITDA for Precision BioSciences?
Precision BioSciences all-time high quarterly EBITDA is $34.69 M
What is Precision BioSciences quarterly EBITDA year-on-year change?
Over the past year, DTIL quarterly EBITDA has changed by -$25.75 M (-243.15%)
What is Precision BioSciences TTM EBITDA?
The current TTM EBITDA of DTIL is $18.82 M
What is the all time high TTM EBITDA for Precision BioSciences?
Precision BioSciences all-time high TTM EBITDA is $24.48 M
What is Precision BioSciences TTM EBITDA year-on-year change?
Over the past year, DTIL TTM EBITDA has changed by +$29.13 M (+282.69%)